Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37725466

about

Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.Research progress on GP73 in malignant tumors

P2860

Q41709493-12663CA2-1C2E-4678-B2D3-469AF817AF0B Q47278009-43DEF039-6F2A-49FA-871B-E00653482F8C Q58694506-89696485-1C81-4886-A006-6C758DFB8EE4

P2860

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37725466

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

@en

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

@nl

type

label

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

@en

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

@nl

prefLabel

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

@en

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

@nl

P1433

Q37725466-8438CDB3-1910-4E89-BCF8-0847B22E5ECA

P1476

Q37725466-AED94244-46F0-4BFC-8CB0-42B4EB00BDD7

P2093

Q37725466-0E86BF18-F173-4302-8585-6A2B652869B2

Q37725466-24801B4F-AE02-4F4D-A370-C184844DAB5B

Q37725466-3599486B-803F-46E9-AB10-B272B023B45E

Q37725466-48B2BBFF-F00B-4977-881E-5FBE205E185E

Q37725466-4FA6BEB3-C633-4BC7-85FA-2EA848A5E779

Q37725466-80EDB154-6A48-459F-A865-23984FF1F863

Q37725466-855275EB-29B2-438B-A614-6F0490797599

Q37725466-96E100D8-41A3-480B-B0D7-B3415EF0229A

Q37725466-A4D0438B-D4B7-4559-9473-795832D20634

Q37725466-F68E7B23-1870-47D7-AB22-6A067A74C4DA

P2860

Q37725466-186F0B52-D85E-4CA5-B5FF-4028BE4939D2

Q37725466-1A539B4C-146D-4B0B-8FEA-AE774E7770E1

Q37725466-25509C97-3688-4829-A6C5-436B7D92A179

Q37725466-2D574DF4-1A59-46B8-B4B9-84F512095BA7

Q37725466-304AFF35-E54A-4312-9D91-9E21F98DD791

Q37725466-33CB0B17-F8F0-4570-BF8C-354B569F953E

Q37725466-35A3E0F0-9E5D-4033-B90F-C4161999A5D4

Q37725466-3DC6EB70-85C7-4652-9F39-9542810DE8B8

Q37725466-4C31AA32-8A58-4622-B60E-E614955836C2

Q37725466-5BFF924C-6E3E-4F83-B1D6-72C0E389FDD3

P304

Q37725466-92D94C22-0695-48ED-B124-CD6564129A9D

P31

Q37725466-A816A425-8A30-4E45-8A9D-BAEC0AAF0CE7

P356

Q37725466-EB3182D6-1E17-43C0-8070-663FC76887E5

P407

Q37725466-C5855F5D-C3ED-4F59-9E2D-148C0FC2F175

P433

Q37725466-7CABFFB2-7B12-4DC1-83EB-EB98BA4549F8

P478

Q37725466-952BF37D-F248-460E-BF30-C1DDAD61E525

P577

Q37725466-CBE37843-CD13-4934-8432-86E36737662B

P698

Q37725466-EE67FCDB-8982-44F8-B3A9-4C6169AC36DA

P921

Q37725466-5ab249f3-8dfc-43c8-ab4a-fb2c6951b986

P932

Q37725466-69D4F1BA-F5AD-4E15-AD87-0122BCF5B631

P356

ONCOTARGET.14954

P1433

P1476

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

@en

P2093

Fengmin Lu

http://www.w3.org/2001/XMLSchema#string

Hui Zhuang

http://www.w3.org/2001/XMLSchema#string

Jidong Jia

http://www.w3.org/2001/XMLSchema#string

Jingmin Zhao

http://www.w3.org/2001/XMLSchema#string

Jinlin Hou

http://www.w3.org/2001/XMLSchema#string

Leijie Wang

http://www.w3.org/2001/XMLSchema#string

Lu Wang

http://www.w3.org/2001/XMLSchema#string

Mingjie Yao

http://www.w3.org/2001/XMLSchema#string

Shuhong Liu

http://www.w3.org/2001/XMLSchema#string

Tianhui Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Hepatitis B virus infection--natural history and clinical consequences

Chronic hepatitis B.

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Diagnosis and management of autoimmune hepatitis.

Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.

AASLD guidelines for treatment of chronic hepatitis B.

P304

16498-16506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.14954

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28157705

http://www.w3.org/2001/XMLSchema#string

P921

P932

5369980

http://www.w3.org/2001/XMLSchema#string